Infollion Research Services Results Update

Infollion Research Services Earnings Call Transcript: Key Takeaways

Infollion reported its strongest half-year performance with revenue reaching ₹60 Cr, driven by international expansion and new verticals like HUKSA. Management is focused on gaining market share through aggressive pricing and AI-related expert use cases.

Infollion Research Services Investor Presentation: Key Takeaways

Infollion reported strong H1 FY27 results with ₹59.04 Cr revenue, up 15.6% YoY. Strategy focuses on AI integration, geographic expansion in US/MENA, and corporate L&D via Huksa.

Infollion Research Services H1 FY27 Results: Net Profit ₹6.7 Cr, Down 8.2% YoY

Infollion Research Services Ltd reported revenue from operations of ₹59 Cr (+15.5% YoY) and net profit of ₹6.7 Cr (-8.2% YoY) for H1 FY27.

Key figure

Net profit ₹6.7 Cr · -8.2% YoY

Infollion Research Services Other Announcement

Infollion Research Services Limited updated its list of authorized personnel for determining materiality under Regulation 30(5). The list includes the Managing Director, CFO, and Company Secretary.

Infollion Research Services Annual General Meeting

Infollion Research Services Limited held its 17th Annual General Meeting on September 17, 2026. Shareholders considered financial statements, director reappointment, and revised remuneration for the MD.

Infollion Research Services Annual General Meeting

Infollion Research Services Limited has issued a notice for its 17th Annual General Meeting scheduled for September 17, 2026, to consider financial statements and director-related matters.

Medi Assist Healthcare Services Results Update

Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.

Neogen Chemicals Results Update

Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.

Surani Steel Tubes Results Update

Surani Steel Tubes issued an earnings press release for H1 FY27, reporting revenue of Rs.290.86 Crore and PAT of Rs.5.94 Crore. The release states that both figures exceed the company's previous full-year records.

Shree Ganesh Remedies Results Update

Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.

Zen Technologies Results Update

Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.

Order book

₹1,376 Cr

Sai Parenterals Results Update

Sai Parenterals reported Q2FY27 consolidated revenue of Rs. 196 crore and PAT of Rs. 11 crore. Gross margin improved to 47.5%.